14.2300.21% ( -0.030 )
Delay Closed: Nov 18, 16:08:04News
CLSA: Further Tightening of US AI Chip Export Controls Favors China's Domestic Supply and Computing Power Chain
AASTOCKS News·- CLSA reported that the US Department of Commerce released a new rule restricting remote access to advanced AI chips and tightening foundry and packaging restrictions. - The broker stated that these export controls will have a limited impact on domestic AI firms with self-sufficient supply chains while favoring local supply capabilities. - The report assigned an Outperform rating to core domestic chip stocks like SMIC and Cambricon, expecting increased investment in domestic AI chip compatibility.Dolphin Daily | No Jensen, New CEO Saves the Day; Software Takes an OpenAI Hit on Anthropic IPO Eve
DolphinResearch·- Nvidia released its first post-leadership-change financial report, showing third-quarter revenue of 115.8 billion dollars that exceeded expectations and raising its fiscal year 2028 revenue growth guidance to about 75 percent. - The U.S. Federal Communications Commission advanced restrictions on Chinese optical transceivers, while OpenAI released a new model that caused a sharp decline in software stocks ahead of Anthropic's pricing. - October retail sales grew by 6.8 percent year-on-year to hit a four-year high, and Federal Reserve officials indicated that multiple rate hikes might be needed before next spring.UBS: China Stocks' Risk-Reward to Improve in 2027; Maintains Barbell Strategy Favoring AI Hardware and Bank Stocks; HSI TP at 26,000 by End-2027
AASTOCKS News·- UBS expects stronger performance for China equities in 2027 with improved risk-reward profiles, setting the end-2027 MSCI China target at 76 and HSI target at 26,000. - Supporting factors include reduced earnings drag, RMB appreciation, lowered tech expectations, and continued government support, with key catalysts linked to AI hardware, US cloud capex, and property stabilization. - The bank maintains a barbell strategy favoring AI tech hardware and banks, while adjusting its model portfolio by adding BeOne Medicines and JD.com.
